Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

MR Elastography Parameters Impact on MR-HIFU Efficacy in Uterine Fibroids

NCT: NCT04345003 · COMPLETED

NCT IDNCT04345003
StatusCOMPLETED
Start Date2020-06-18
Completion2023-08-31

Brief Summary

Magnetic resonance (MR)-guided high-intensity focused ultrasound (HIFU) ablation for fibroids is an outpatient approach for controlling symptom with an excellent safety record. It is important to exclude in advance patients who would not benefit from this treatment. For that purpose this study assesses the influence of fibroid elasticity and diffusion on ablation efficiency during treatment by MR-HIFU

Frequently Asked Questions

What is MR Elastography Parameters Impact on MR-HIFU Efficacy in Uterine Fibroids?

MR Elastography Parameters Impact on MR-HIFU Efficacy in Uterine Fibroids is a clinical trial registered under NCT04345003. Current status: COMPLETED.

What is the status of NCT04345003?

The current status of NCT04345003 (MR Elastography Parameters Impact on MR-HIFU Efficacy in Uterine Fibroids) is: COMPLETED.

When did MR Elastography Parameters Impact on MR-HIFU Efficacy in Uterine Fibroids start?

MR Elastography Parameters Impact on MR-HIFU Efficacy in Uterine Fibroids started on 2020-06-18.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑